๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA study

โœ Scribed by Michel E. Bertrand; Roberto Ferrari; Wilhelm J. Remme; Maarten L. Simoons; Jaab W. Deckers; K.M. Fox

Book ID
116192028
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
460 KB
Volume
159
Category
Article
ISSN
1097-6744

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Trial suggests that perindopril reduces
Trial suggests that perindopril reduces major cardiovascular events among people with stable coronary artery disease: Abstracted from: The EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003; 362(9386): 782โ€“8
๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 131 KB